Lensar (LNSR) Income towards Parent Company (2019 - 2026)
Lensar's (LNSR) quarterly Income towards Parent Company came in at -$42000.0 in Q1 2026, up 99.81% year-on-year from -$21020.0 in Q1 2025, and up 99.75% on a QoQ basis from -$16.5 million in Q4 2025.
Lensar (LNSR) Income towards Parent Company (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Income towards Parent Company data on file, last reported at -$42000.0 in Q1 2026.
- On a quarterly basis, Income towards Parent Company rose 99.81% year-over-year to -$42000.0 in Q1 2026; TTM through Mar 2026 was -$58.0 million, a 45.02% decrease from a year earlier, with the FY2025 full-year figure at -$36.2 million, down 106.41% from the prior year.
- Income towards Parent Company for Q1 2026 stood at -$42000.0, up from -$16.5 million in the prior quarter.
- Over the last five years, Income towards Parent Company for LNSR reached as high as -$42000.0 in Q1 2026 and fell as low as -$22.1 million in Q1 2025.
- Historically, Income towards Parent Company has averaged -$9.7 million across 5 years, with a median of -$8.2 million in 2024.
- Across the five-year window, Income towards Parent Company plunged 539.88% in 2025 and surged 99.81% in 2026, its largest moves.
- Year by year, Income towards Parent Company stood at -$3.3 million in 2022, then retreated by 3.64% to -$3.4 million in 2023, then tumbled by 140.65% to -$8.2 million in 2024, then plunged by 102.34% to -$16.5 million in 2025, then soared by 99.75% to -$42000.0 in 2026.
- Per Business Quant data, the three most recent Income towards Parent Company figures were -$42000.0 in Q1 2026, -$16.5 million in Q4 2025, and -$20.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Lensar | 65.43 Mn | 54.33 Mn | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42,000.00 |
| Dec 31, 2025 | -16.51 Mn |
| Sep 30, 2025 | -20.59 Mn |
| Jun 30, 2025 | -20.85 Mn |
| Mar 31, 2025 | -22.12 Mn |
| Dec 31, 2024 | -8.16 Mn |
| Sep 30, 2024 | -3.22 Mn |
| Jun 30, 2024 | -6.48 Mn |
| Mar 31, 2024 | -7.27 Mn |
| Dec 31, 2023 | -3.39 Mn |
| Sep 30, 2023 | -7.26 Mn |
| Jun 30, 2023 | -4.08 Mn |
| Mar 31, 2023 | -9.54 Mn |
| Dec 31, 2022 | -3.27 Mn |
| Sep 30, 2022 | -10.27 Mn |
| Jun 30, 2022 | -11.14 Mn |
| Mar 31, 2022 | -11.03 Mn |
| Dec 31, 2021 | -4.43 Mn |
| Sep 30, 2021 | -11.57 Mn |
| Jun 30, 2021 | -9.78 Mn |